| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2672985C Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia |
| 06/11/2013 | CA2559161C Irna agents targeting vegf |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/11/2013 | CA2406277C Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 06/06/2013 | WO2013082565A1 Therapies for disorders of the cornea and conjunctiva |
| 06/06/2013 | WO2013082563A1 Protein inhibitors to complement and vegf pathways and methods of use thereof |
| 06/06/2013 | WO2013081981A1 Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for retinal neuroprotection |
| 06/06/2013 | WO2013081118A1 Compound having read-through activity |
| 06/06/2013 | WO2013079713A1 Improving trabeculectomy outcome |
| 06/06/2013 | WO2013079696A1 Methods of treatment and prevention of eye diseases |
| 06/06/2013 | WO2013079213A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome |
| 06/06/2013 | WO2013078998A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine |
| 06/06/2013 | US20130143922 Thio compounds |
| 06/06/2013 | CA2857546A1 Methods of treatment and prevention of eye diseases |
| 06/06/2013 | CA2857168A1 Protein inhibitors to complement and vegf pathways and methods of use thereof |
| 06/06/2013 | CA2857008A1 Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for retinal neuroprotection |
| 06/06/2013 | CA2855223A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome |
| 06/05/2013 | EP2599498A1 Composition for ophthalmic disease associated with hypoxia or ischemia |
| 06/05/2013 | EP2598500A1 Compositions and methods for inhibition of the jak pathway |
| 06/05/2013 | EP2598131A1 Compounds for the treatment/prevention of ocular inflammatory diseases |
| 06/05/2013 | EP2598109A1 Preservative-free composition for topical use including hyaluronic acid |
| 06/05/2013 | CN103140217A Combination of compounds for treating or preventing skin diseases |
| 06/05/2013 | CN103130859A Difluprednate crystal form I and preparation method thereof |
| 06/05/2013 | CN103130735A Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| 06/05/2013 | CN103127456A Medicine patch for treating acute contagious conjunctivitis |
| 06/05/2013 | CN103127408A Chinese medicine preparation method capable of curing heat-toxin type acute contagious conjunctivitis |
| 06/05/2013 | CN103127293A Traditional Chinese medicine composition for treating allergic conjunctivitis |
| 06/05/2013 | CN103127282A Traditional Chinese medicine compound for treating tinnitus |
| 06/05/2013 | CN103127265A Traditional Chinese medicine composition for treating otitis media |
| 06/05/2013 | CN103127233A Traditional Chinese medicine for treating eye diseases, and its production method |
| 06/05/2013 | CN103127139A Difluprednate topical external preparation |
| 06/05/2013 | CN103127100A Formulation and method for vascular permeability-related diseases or conditions |
| 06/05/2013 | CN103127096A Application of pyrryl-substituted indole compound in curing glaucoma |
| 06/05/2013 | CN103127033A Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye |
| 06/05/2013 | CN103127030A Propylene glycol alginate sodium sulfate enteric capsule and preparation method thereof |
| 06/05/2013 | CN103127024A Stable disodium adenosine triphosphate tablet |
| 06/05/2013 | CN103127004A Propylene glycol alginate sodium sulfate controlled-release granule and preparation method thereof |
| 06/05/2013 | CN103126981A Foscarnet sodium eye drops and preparation method |
| 06/05/2013 | CN103125946A Lutein nanoparticle and its preparation method |
| 06/05/2013 | CN102309535B Traditional Chinese drug plaster for treating tinnitus |
| 06/05/2013 | CN102178936B Methods for preparing collagen oleostock and moistening eyedrops |
| 06/05/2013 | CN101991612B Preparation method of haematococcus pluvialis extracts |
| 06/05/2013 | CN101657445B Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure |
| 06/05/2013 | CN101641104B Therapeutic agent for infectious skin or mucosal disease |
| 06/05/2013 | CN101260398B Nerve growth factor gene positioning reconstruction animal and its preparation method and application |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455494 Preparations and methods for ameliorating or reducing presbyopia |
| 06/04/2013 | US8455492 Methods for treating retinal diseases |
| 06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
| 06/04/2013 | CA2542609C Novel indazole derivatives |
| 06/04/2013 | CA2432301C Lentiviral vector-mediated gene transfer and uses thereof |
| 05/30/2013 | WO2013078151A1 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases |
| 05/30/2013 | WO2013077579A1 Pharmaceutical composition for preventing and treating ophthalmic disorders |
| 05/30/2013 | WO2013077433A1 Keratoconjunctival protecting agent, or keratoconjunctival disorder inhibiting agent |
| 05/30/2013 | WO2013076063A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/30/2013 | US20130137742 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 05/30/2013 | US20130137657 Quaternised ammonium cyclodextrin compounds |
| 05/30/2013 | CA2856680A1 Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder |
| 05/30/2013 | CA2856507A1 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases |
| 05/30/2013 | CA2854569A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/29/2013 | EP2595625A1 Pharmaceutical composition containing a tryptophan derivative |
| 05/29/2013 | EP2595614A1 Composition for retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline |
| 05/29/2013 | CN1829740B Connective tissue growth factor antibodies |
| 05/29/2013 | CN1826121B Use of phenyl and pyridyl derivative for modulating calcium ion-release-activated calcium ion channels |
| 05/29/2013 | CN103122298A Magnet healthcare medicated wine |
| 05/29/2013 | CN103121973A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103120767A Traditional Chinese medicine for treating diabetic retinopathy and preparation method thereof |
| 05/29/2013 | CN103120761A Traditional Chinese medicine for treating senile xerophthalmia |
| 05/29/2013 | CN103120744A Chinese medicinal composition for removing abnormal phlegm and preparation method thereof |
| 05/29/2013 | CN103120741A Medicine for treating Meniere disease |
| 05/29/2013 | CN103120714A Chinese medicinal preparation for treating suppurative otitis media |
| 05/29/2013 | CN103120701A Application of gag including hydrophobic group in preparation of drug for preventing or treating epithelium |
| 05/29/2013 | CN103120690A Pharmaceutical composition for treatment of cataract |
| 05/29/2013 | CN102626390B Gastrodin multiphase liposome injection |
| 05/29/2013 | CN102178928B Application of cobra venom neurotoxin in drugs for treating ametropia |
| 05/29/2013 | CN102038644B Lutein water-soluble powder and preparation process thereof |
| 05/29/2013 | CN101693714B Spirocyclic cyclohexane derivatives |
| 05/29/2013 | CN101506145B Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | CA2736380C Compositions comprising polymers having amino sugar units and methods of making and using same |
| 05/28/2013 | CA2563260C Methods of treating autoimmune and inflammatory diseases |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2476935C Drug delivery system for subconjunctival administration of fine particles |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/23/2013 | WO2013075068A1 Polymer protein microparticles |
| 05/23/2013 | WO2013075008A1 Aav dual vector systems for gene therapy |
| 05/23/2013 | WO2013074840A1 Treatment of dry age related macular degeneration |
| 05/23/2013 | WO2013074681A1 Pharmaceutical preparations of human rpe cells and uses thereof |
| 05/23/2013 | WO2013074608A1 Cyclosporine a form 2 and method of making same |
| 05/23/2013 | WO2008147883A8 Prevention and treatment of complement-associated eye conditions |
| 05/23/2013 | US20130131052 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | CA2856034A1 Cyclosporine a form 2 and method of making same |
| 05/23/2013 | CA2855941A1 Pharmaceutical preparations of human rpe cells and uses thereof |
| 05/23/2013 | CA2855749A1 Polymer protein microparticles |
| 05/22/2013 | EP2594274A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 05/22/2013 | EP2594267A1 Protective Agent for Retinal Nerve or Optic Nerve |
| 05/22/2013 | EP2594264A1 Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective rtk inhibitors |